Skip to Content

News Releases

Nov 07 2022
RxSight, Inc. Reports Third Quarter 2022 Financial Results
ALISO VIEJO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2022.
Oct 24 2022
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the third quarter 2022 after the market close
Aug 24 2022
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference.
Aug 08 2022
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program
ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it has filed a $200 million shelf registration statement on Form S-3 with the
Aug 08 2022
RxSight, Inc. Reports Second Quarter 2022 Financial Results
ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three and six months ended June 30, 2022.
Jul 25 2022
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022
ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the second quarter 2022 after the market
May 05 2022
RxSight, Inc. Reports First Quarter 2022 Financial Results
ALISO VIEJO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended March 31, 2022.
Apr 22 2022
RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) --  RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.
Apr 21 2022
RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022 
ALISO VIEJO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – April 21, 2022 – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the first quarter 2022
Apr 19 2022
Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)  -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that its Light Adjustable Lens system, comprised of the RxSight Light Adjustable
Displaying 1 - 10 of 16